N-acetylcysteine for treatment of autism, a case report

Journal of Research in Medical Sciences

Volumn 17, Issue 10, 2012, Pages 985-987

  Ghanizadeh, Ahmad ^a,b   Derakhshan, Nima ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autism; Children; Glutathione; Oxidative stress; Treatment

Indexed keywords

ACETYLCYSTEINE;

ABDOMINAL PAIN; AGGRESSION; ARTICLE; AUTISM; CASE REPORT; CHILD; COMMUNICATION DISORDER; DISEASE SEVERITY; EYELID REFLEX; HABIT; HUMAN; HYPERACTIVITY; MALE; NERVOUS SYSTEM INFLAMMATION; OXIDATIVE STRESS; SCHOOL CHILD; SOCIAL INTERACTION; VISUAL ANALOG SCALE;

EID: 84872200954     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Malik M, Sheikh AM, Wen G, Spivack W, Brown WT, Li X. Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 2011;216:80-5.
2. Ghanizadeh A. Could fever and neuroinflammation play a role in the neurobiology of autism? A subject worthy of more research. Int J Hyperthermia 2011;27:737-8.
3. Ghanizadeh A. Hyperbaric oxygen therapy for treatment of children with autism: A systematic review of randomized trials. Med Gas Res 2012;2:13.
4. Sansone RA, Sansone LA. Getting a knack for NAC: N-acetyl-cysteine. Innov Clin Neurosci 2011;8:10-4.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4 th ed. Washington, DC: American Psychiatric Association; 2000.
6. Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 2011;36:78-86.
7. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR. A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 2009;34:386-93.
8. Geier DA, Geier MR. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res 2006;66:182-8.
9. Pastural E, Ritchie S, Lu Y, Jin W, Kavianpour A, Khine Su-Myat K, et al. Novel plasma phospholipid biomarkers of autism: Mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot Essent Fatty Acids 2009;81:253-64.
10. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004;80:1611-7.
11. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, et al. Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci 2009;280:101-8.
12. James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, et al. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 2009;89:425-30.
13. Ghanizadeh A. A novel hypothesized clinical implication of zonisamide for autism. Ann Neurol 2011;69:426; author reply 426-7.
14. Ghanizadeh A. Targeting neurotensin as a potential novel approach for the treatment of autism. J Neuroinflammation 2010;7:58.
15. Angelidou A, Francis K, Vasiadi M, Alysandratos KD, Zhang B, Theoharides A, et al. Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation 2010;7:48.
16. Ghanizadeh A. Methionine sulfoximine may improve inflammation in autism, a novel hypothesized treatment for autism. Arch Med Res 2010;41:651-2.
17. Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: A randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacology 2001;37:2143-52.
18. Ghanizadeh A. Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment. Neurochem Res 2011;36:922-3.
19. Ghanizadeh A. Hydrogen as a novel hypothesized emerging treatment for oxidative stress in autism. Eur Rev Med Pharmacol Sci. 2012;16(9):1313-4.
20. Ghanizadeh A. Physical exercise and intermittent administration of lactulose may improve autismsymptoms through hydrogen production. Med Gas Res. 2012 Jul 30;2(1):19.
21. Ghanizadeh A, Akhondzadeh S, Hormozi M, Makarem A, Abotorabi-Zarchi M, Firoozabadi A. Glutathione-related factors and oxidative stress in autism, a review. Curr Med Chem. 2012;19(23):4000-5.